<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml" xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:ms="urn:schemas-microsoft-com:xslt" xmlns:dt="urn:schemas-microsoft-com:datatypes">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <style type="text/css">
					body { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-style: italic;
					font-weight: bold;
					}

					a {
					color: #039;
					text-decoration: none;
					}
					
					.block {
					margin: 0 3em 1em;
					}

					p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					padding: 0;
					text-align: left;
					}

					ul {
					list-style-type: disc;
					margin: 0 3em 1em;
					padding: 0;
					}

					ol {
					list-style-type: decimal;
					margin: 0;
					overflow: hidden;
					padding: 0;
					padding-left: 2em;
					}

					li {
					margin-left: 1.5em;
					margin-top: 0.7em;
					}

					table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					table-layout: auto;
					}

					th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					div#wrapper { width: 650px; }

					div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					div#Sections { width: 650px; }

					div#Sections table { page-break-inside: avoid; }

					div#Codebook {
					width: 650px;
					page-break-after: always;
					}

					div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					div#References {
					page-break-after: always;
					width: 650px;
					}

					div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					position: relative;
					width: 600px;
					}

					span.file-size { color: gray; }

					.pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</style>
    <style type="text/css" media="print">
					div#toc { display: none; }
				</style>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="Keywords" content="Surveys,Data Collection,NCHS,NHANES,National Health and Nutrition Examination Survey,data,documentation,Hepatitis E: IgG &amp; IgM Antibodies" />
    <meta name="DC.Subject" content="NHANES 2015-2016: Hepatitis E: IgG &amp; IgM Antibodies Data Documentation" />
    <meta name="DC.Language" scheme="ISO 639-2" content="eng" />
    <link rel="Prev" Title="NHANES 2015-2016 Laboratory page" href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory&amp;CycleBeginYear=2015">
      <title>
						NHANES 2015-2016:
						Hepatitis E: IgG &amp; IgM Antibodies Data Documentation, Codebook, and Frequencies</title>
    </link>
  </head>
  <body>
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <div id="CodebookLinks">
              <ul>
                <li>
                  <a href="#SEQN">SEQN - Respondent sequence number</a>
                </li>
                <li>
                  <a href="#LBDHEG">LBDHEG   - Hepatitis E IgG (anti-HEV)</a>
                </li>
                <li>
                  <a href="#LBDHEM">LBDHEM   - Hepatitis E IgM (anti-HEV)</a>
                </li>
              </ul>
            </div>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader" xmlns="">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2015-2016 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Hepatitis E: IgG &amp; IgM Antibodies (HEPE_I)
			</h3>
        <h4>
				Data File: HEPE_I.xpt
			</h4>
        <h5 class="left">
				First Published:
				September 2017</h5>
        <h5 class="right">
				Last Revised:
				
						NA
					</h5>
      </div>
      <div id="Sections" xmlns="">
        <h2 id="Component_Description">Component Description</h2>
        <div class="block"><p>Hepatitis viruses constitute a major public health problem because of the morbidity and mortality associated with the acute and chronic consequences of these infections. New immunization strategies have been developed to eliminate the spread of hepatitis B virus (HBV) and hepatitis A virus (HAV) in the United States. Recommendations have also been developed for the prevention and control of hepatitis C virus (HCV) infection. Infection with hepatitis E virus (HEV) has been responsible for large water-borne epidemics of acute disease in developing countries and for acute sporadic disease in industrialized developed countries. In immunocompromised individuals, infection with HEV may also cause chronic infection, which may progress to fibrosis and cirrhosis. Because of the high rate of asymptomatic infection with these viruses, information about the prevalence of these diseases is needed to monitor prevention efforts. By testing a nationally representative sample of the U.S. population, NHANES will provide the most reliable estimates of age-specific prevalence needed to evaluate the effectiveness of the strategies to prevent these infections. In addition, NHANES provides the means to better define the epidemiology of other hepatitis viruses. NHANES testing for markers of infection with hepatitis viruses will be used to determine secular trends in infection rates across most age and racial/ethnic groups, and will provide a national picture of the epidemiologic determinants of these infections.</p></div>
        <h2 id="Eligible_Sample">Eligible Sample</h2>
        <div class="block"><p>Examined participants aged&nbsp;6 years or older were eligible.</p></div>
        <h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2>
        <div class="block"><p><strong>Hepatitis E IgG Antibody (IgG Anti-HEV)
</strong></p>
<p>DS-EIA-ANTI-HEV-G is an enzyme immunoassay kit intended for the detection of IgG antibodies to hepatitis E virus in human serum or plasma. During an initial incubation, HEV antibody in the sample binds with HEV antigen coated onto wells of a polystyrene stripped plate. Unbound sample is removed by washing. During a second incubation, horseradish peroxidase-labeled antibody conjugate (monoclonal mouse antibodies against human IgG) binds to any human IgG from the sample that was captured on the well. Unbound conjugate is removed by washing and a substrate solution containing tetramethylbenzidine is added to produce color. The reaction is stopped by adding a sulphuric acid solution and the optical density (OD) of each well is read. The presence or absence of IgG antibodies to hepatitis E virus is determined by the ratio of the OD of each sample to the calculated cut-off value. A sample is considered negative if the sample OD value is &lt; cut-off and is considered positive if the sample OD value is &ge; cut-off. </p>
<p><strong>Hepatitis E IgM Antibody (IgM Anti-HEV)
</strong></p>
<p>DS-EIA-ANTI-HEV-M is an enzyme immunoassay kit intended for the detection of IgM antibodies to hepatitis E virus in human serum or plasma. During an initial incubation, HEV antibody in the sample binds with HEV antigen coated onto wells of a polystyrene stripped plate. Unbound sample is removed by washing. During a second incubation, horseradish peroxidase-labeled antibody conjugate (monoclonal mouse antibodies against human IgM) binds to any human IgM from the sample that was captured on the well. Unbound conjugate is removed by washing and a substrate solution containing tetramethylbenzidine is added to produce color. The reaction is stopped by adding a sulphuric acid solution and the OD of each well is read. The presence or absence of IgM antibodies to hepatitis E virus is determined by the ratio of the OD of each sample to the calculated cut-off value. A sample is considered negative if the sample OD value is &lt; cut-off and is considered positive if the sample OD value is &ge; cut-off. </p>
<p>Refer to the Laboratory Method Files section for a detailed description of the laboratory methods used. </p>
<p>There were no changes to laboratory methods, lab equipment, or lab site for this component in the 2015-2016 cycle.
<br />
</p></div>
        <h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <div class="block">
          <p><a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/HEPE_I_MET_HEPATITIS_E_IgG_ANTIBODY.pdf">IgG Hepatitis E Antibody</a><span> (September 2017)</span></p>
          <p><a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/HEPE_I_MET_HEPATITIS_E_IgM_ANTIBODY.pdf">IgM Hepatitis E Antibody</a><span> (September 2017)</span></p>
        </div>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2>
        <div class="block"><p>Serum specimens were processed, stored, and shipped to the Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention.
</p>
<p>Detailed instructions on specimen collection and processing are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/manuals/2016_MEC_Laboratory_Procedures_Manual.pdf">NHANES Laboratory Procedures Manual (LPM)</a>. Vials are stored under appropriate frozen (&ndash;30&deg;C) conditions until they are shipped to Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention for testing.</p>
<p>The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/manuals/2016_MEC_Laboratory_Procedures_Manual.pdf">NHANES LPM</a>. </p>
<p><strong>Mobile Examination Centers (MECs)</strong> </p>
<p>Laboratory team performance is monitored using several techniques. NCHS and contract consultants use a structured competency assessment evaluation during visits to evaluate both the quality of the laboratory work and the quality-control procedures. Each laboratory staff member is observed for equipment operation, specimen collection and preparation; testing procedures and constructive feedback are given to each staff member. Formal retraining sessions are conducted annually to ensure that required skill levels were maintained. </p>
<p><strong>Analytical Laboratories </strong></p>
<p>NHANES uses several methods to monitor the quality of the analyses performed by the contract laboratories. In the MEC, these methods include performing blind split samples collected on &ldquo;dry run&rdquo; sessions. In addition, contract laboratories randomly perform repeat testing on 2% of all specimens.<br />
</p></div>
        <h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2>
        <div class="block"><p>The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.</p></div>
        <h2 id="Analytic_Notes">Analytic Notes</h2>
        <div class="block"><p>Refer to the <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2015">2015-2016 Laboratory Data Overview</a> for general information on NHANES laboratory data.</p>
<p><strong>Demographic and Other Related Variables</strong></p>
<p>The analysis of NHANES laboratory data must be conducted using the appropriate survey design and demographic variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2015">NHANES 2015-2016 Demographics File</a> contains demographic data, health indicators, and other related information collected during household interviews as well as the sample design variables. The recommended procedure for variance estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data file. <br />
</p>
<p>This laboratory data file can be linked to the other NHANES data files using the unique survey participant identifier (i.e., SEQN). <br />
</p>
<p><strong>Detection Limits </strong></p>
<p>This data is qualitative. The use of lower limits of detection (LLODs) is not applicable. </p>
<p>Exam sample weights should be used for analyses. Please refer to the NHANES
<a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx">Analytic Guidelines</a> and the on-line NHANES <a href="https://www.cdc.gov/nchs/tutorials/">Tutorial</a>  for further details on the use of sample weights and other analytic issues. </p></div>
      </div>
      <div id="Codebook" xmlns="">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHEG">LBDHEG   - Hepatitis E IgG (anti-HEV)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHEG  </dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis E IgG (anti-HEV)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis E IgG (anti-HEV)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">537</td>
                <td class="values" align="right">537</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">6587</td>
                <td class="values" align="right">7124</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">7124</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">897</td>
                <td class="values" align="right">8021</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHEM">LBDHEM   - Hepatitis E IgM (anti-HEV)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHEM  </dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis E IgM (anti-HEV)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis E IgM (anti-HEV)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">90</td>
                <td class="values" align="right">90</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">7034</td>
                <td class="values" align="right">7124</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">7124</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">897</td>
                <td class="values" align="right">8021</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>